PAVmed Analyst Ratings
PAVmed Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/17/2022 | 193.26% | Lake Street | $7 → $5 | Maintains | Buy |
| 03/30/2021 | 369.21% | Cantor Fitzgerald | → $8 | Initiates Coverage On | → Overweight |
| 11/05/2020 | 193.26% | Ascendiant Capital | → $5 | Initiates Coverage On | → Buy |
| 10/13/2020 | 193.26% | Lake Street | → $5 | Initiates Coverage On | → Buy |
| 06/28/2018 | 193.26% | Maxim Group | → $5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/17/2022 | 193.26% | 湖街 | 7 美元 → 5 美元 | 维护 | 买 |
| 03/30/2021 | 369.21% | 坎托·菲茨杰拉德 | → 8 美元 | 启动覆盖范围开启 | → 超重 |
| 2020 年 5 月 11 日 | 193.26% | 上升资本 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 2020 年 10 月 13 日 | 193.26% | 湖街 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
| 06/28/2018 | 193.26% | Maxim 集团 | → 5 美元 | 启动覆盖范围开启 | → 购买 |
PAVmed Questions & Answers
PavMed 问题与解答
The latest price target for PAVmed (NASDAQ: PAVM) was reported by Lake Street on August 17, 2022. The analyst firm set a price target for $5.00 expecting PAVM to rise to within 12 months (a possible 193.26% upside). 1 analyst firms have reported ratings in the last year.
莱克街于2022年8月17日公布了PavMed（纳斯达克股票代码：PAVM）的最新目标股价。该分析公司将目标股价定为5.00美元，预计PAVM将在12个月内升至12个月内（可能上涨193.26％）。1家分析公司去年公布了评级。
The latest analyst rating for PAVmed (NASDAQ: PAVM) was provided by Lake Street, and PAVmed maintained their buy rating.
PavMed（纳斯达克股票代码：PAVM）的最新分析师评级由莱克街提供，PavMed维持买入评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of PAVmed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for PAVmed was filed on August 17, 2022 so you should expect the next rating to be made available sometime around August 17, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表、与PavMed的高管和客户交谈以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。PavMed的最新评级是在2022年8月17日发布的，因此您应该预计下一个评级将在2023年8月17日左右公布。
While ratings are subjective and will change, the latest PAVmed (PAVM) rating was a maintained with a price target of $7.00 to $5.00. The current price PAVmed (PAVM) is trading at is $1.71, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的PavMed（PAVM）评级保持不变，目标股价为7.00美元至5.00美元。PavMed（PAVM）目前的交易价格为1.71美元，超出了分析师的预期区间。